Amwill Health Care Limited (BOM:544353)

Market Cap	759.74M -50.3%
Revenue (ttm)	386.31M -7.7%
Net Income	80.88M
EPS	4.40
Shares Out	20.00M
PE Ratio	8.63
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,800
Average Volume	13,140
Open	37.25
Previous Close	37.25
Day's Range	37.25 - 38.00
52-Week Range	28.91 - 104.90
Beta	n/a
RSI	66.99
Earnings Date	May 29, 2026

About Amwill Health Care

Amwill Health Care Limited, a derma-cosmetic company, engages in the development and contract manufacturing of generic dermatological solutions in India. It offers product formulations for anti-acne, dry skin, anti-aging, anti-fungal, anti-histaminic, anti-perspirant, antibiotics, skin lightening, hair care, steroid and keratolytic, sunscreen, vitiligo, miscellaneous, peri-orbital hyperpigmentation, anti-scar, topical antibiotics, antioxidants, and anti-scabies, as well as cosmeceutical and aesthetic categories. The company was founded in 2009 ...

• Industry: Pharmaceutical Preparations
• Founded: 2009
• Employees: 88
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544353

Financial Performance

In fiscal year 2025, Amwill Health Care's revenue was 405.82 million, a decrease of -7.66% compared to the previous year's 439.48 million. Earnings were 107.30 million, a decrease of -14.16%.